Utah Medical Products is a medical instruments & supplies business based in the US. Utah Medical Products shares (UTMD) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $64.18 – a decrease of 3.52% over the previous week. Utah Medical Products employs 169 staff and has a trailing 12-month revenue of around $44.1 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $64.18 |
|---|---|
| 52-week range | $63.38 - $85.86 |
| 50-day moving average | $66.03 |
| 200-day moving average | $68.25 |
| Wall St. target price | N/A |
| PE ratio | 15.6518 |
| Dividend yield | $1.2 (1.82%) |
| Earnings per share (TTM) | $4.25 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $64.69 from 2024-11-19
| 1 week (2024-11-14) | -2.75% |
|---|---|
| 1 month (2024-10-21) | -1.64% |
| 3 months (2024-08-21) | -3.98% |
| 6 months (2024-05-21) | -5.88% |
| 1 year (2023-11-21) | -22.39% |
|---|---|
| 2 years (2022-11-21) | -27.19% |
| 3 years (2021-11-19) | 109.12 |
| 5 years (2019-11-21) | 93.1565 |
Valuing Utah Medical Products stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Utah Medical Products's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Utah Medical Products's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, Utah Medical Products shares trade at around 16x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Utah Medical Products's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $20.1 million.
The EBITDA is a measure of a Utah Medical Products's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $44.1 million |
|---|---|
| Operating margin TTM | 37.54% |
| Gross profit TTM | $32.2 million |
| Return on assets TTM | 8.18% |
| Return on equity TTM | 12.31% |
| Profit margin | 34.62% |
| Book value | $36.10 |
| Market Capitalization | $228.9 million |
TTM: trailing 12 months
Dividend payout ratio: 28.06% of net profits
Recently Utah Medical Products has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Utah Medical Products shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Utah Medical Products's case, that would currently equate to about $1.2 per share.
While Utah Medical Products's payout ratio might seem fairly standard, it's worth remembering that Utah Medical Products may be investing much of the rest of its net profits in future growth.
Utah Medical Products's most recent dividend payout was on 3 October 2024. The latest dividend was paid out to all shareholders who bought their shares by 15 December 2024 (the "ex-dividend date").
Utah Medical Products's shares were split on a 3:2 basis on 21 March 1993 . So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Utah Medical Products shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Utah Medical Products shares which in turn could have impacted Utah Medical Products's share price.
Over the last 12 months, Utah Medical Products's shares have ranged in value from as little as $63.38 up to $85.8621. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Utah Medical Products's is 0.08. This would suggest that Utah Medical Products's shares are less volatile than average (for this exchange).
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO, an umbilical vessel catheters, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation devices; suprapubic catheterization; LIBERTY, an urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; high-pressure and piezo-resistive transducer assemblies; and pressure monitoring accessories, components, and other molded parts.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.